Ligers A - Search Results

1

Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis.

Ligers A, Dyment DA, Willer CJ, Sadovnick AD, Ebers G, Risch N, Hillert J; Canadian Collaborative Study Groups. Ligers A, et al. Am J Hum Genet. 2001 Oct;69(4):900-3. doi: 10.1086/323480. Epub 2001 Aug 22. Am J Hum Genet. 2001. PMID: 11519010 Free PMC article.

2

Sharing of a conserved haplotype suggests a susceptibility gene for multiple sclerosis at chromosome 17p11.

He B, Giedraitis V, Ligers A, Binzer M, Andersen PM, Forsgren L, Sandkuijl LA, Hillert J. He B, et al. Among authors: ligers a. Eur J Hum Genet. 2002 Apr;10(4):271-5. doi: 10.1038/sj.ejhg.5200802. Eur J Hum Genet. 2002. PMID: 12032736

3

The CTLA-4 gene is associated with multiple sclerosis.

Ligers A, Xu C, Saarinen S, Hillert J, Olerup O. Ligers A, et al. J Neuroimmunol. 1999 Jun 1;97(1-2):182-90. doi: 10.1016/s0165-5728(99)00072-7. J Neuroimmunol. 1999. PMID: 10408973

4

Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease.

Fogdell-Hahn A, Ligers A, Grønning M, Hillert J, Olerup O. Fogdell-Hahn A, et al. Among authors: ligers a. Tissue Antigens. 2000 Feb;55(2):140-8. doi: 10.1034/j.1399-0039.2000.550205.x. Tissue Antigens. 2000. PMID: 10746785

5

HLA-DR15 is associated with lower age at onset in multiple sclerosis.

Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J. Masterman T, et al. Among authors: ligers a. Ann Neurol. 2000 Aug;48(2):211-9. Ann Neurol. 2000. PMID: 10939572

6

CTLA4 dimorphisms and the multiple sclerosis phenotype.

Masterman T, Ligers A, Zhang Z, Hellgren D, Salter H, Anvret M, Hillert J. Masterman T, et al. Among authors: ligers a. J Neuroimmunol. 2002 Oct;131(1-2):208-12. doi: 10.1016/s0165-5728(02)00274-6. J Neuroimmunol. 2002. PMID: 12458054

7

No linkage or association of a VNTR marker in the junction region of the immunoglobulin heavy chain genes in multiple sclerosis.

Ligers A, He B, Fogdell-Hahn A, Olerup O, Hillert J. Ligers A, et al. Eur J Immunogenet. 1997 Aug;24(4):259-64. doi: 10.1111/j.1365-2370.1997.tb00019.x. Eur J Immunogenet. 1997. PMID: 9306094

8

CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms.

Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J. Ligers A, et al. Genes Immun. 2001 May;2(3):145-52. doi: 10.1038/sj.gene.6363752. Genes Immun. 2001. PMID: 11426323

9

Genetic susceptibility to MS: a second stage analysis in Canadian MS families.

Dyment DA, Willer CJ, Scott B, Armstrong H, Ligers A, Hillert J, Paty DW, Hashimoto S, Devonshire V, Hooge J, Kastrukoff L, Oger J, Metz L, Warren S, Hader W, Power C, Auty A, Nath A, Nelson R, Freedman M, Brunet D, Paulseth JE, Rice G, O'Connor P, Duquette P, Lapierre Y, Francis G, Bouchard JP, Murray TJ, Bhan V, Maxner C, Pryse-Phillips W, Stefanelli M, Sadovnick AD, Risch N, Ebers GC. Dyment DA, et al. Among authors: ligers a. Neurogenetics. 2001 Jul;3(3):145-51. doi: 10.1007/s100480100113. Neurogenetics. 2001. PMID: 11523565

10

CTLA-4 dimorphisms in gammopathy-associated peripheral neuropathy.

Masterman T, Ligers A, Olerup O, Vrethem M, Hillert J. Masterman T, et al. Among authors: ligers a. Eur J Neurol. 1999 Jul;6(4):491-3. doi: 10.1046/j.1468-1331.1999.640491.x. Eur J Neurol. 1999. PMID: 10362905 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page